| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |